Literature DB >> 17132577

A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.

Alison Ritter1, Jacqui Cameron.   

Abstract

Harm reduction is both a policy approach and used to describe a specific set of interventions. These interventions aim to reduce the harms associated with drug use. Employing a strict definition of harm reduction, evidence for the efficacy and effectiveness of alcohol, tobacco and illicit drug harm reduction interventions were reviewed. Systematic searches of the published literature were undertaken. Studies were included if they provided evaluation data (pre-post, or control group comparisons). More than 650 articles were included in the review. The majority of the literature concerned illicit drugs. For alcohol, harm reduction interventions to reduce road trauma are well-founded in evidence. Otherwise, there is limited research to support the efficacy and effectiveness of other alcohol harm reduction interventions. For tobacco, the area is controversial but promising new products that reduce the harms associated with smoking are being developed. In the area of illicit drugs there is solid efficacy, effectiveness and economic data to support needle syringe programmes and outreach programmes. There is limited published evidence to date for other harm reduction interventions such as non-injecting routes of administration, brief interventions and emerging positive evidence for supervised injecting facilities. There is sufficient evidence to support the wide-spread adoption of harm reduction interventions and to use harm reduction as an overarching policy approach in relation to illicit drugs. The same cannot be concluded for alcohol or tobacco. Research at a broad policy level is required, especially in light of the failure by many policy makers to adopt cost-effective harm reduction interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132577     DOI: 10.1080/09595230600944529

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  33 in total

1.  High Prevalence of Assisted Injection Among Street-Involved Youth in a Canadian Setting.

Authors:  Tessa Cheng; Thomas Kerr; Will Small; Huiru Dong; Julio Montaner; Evan Wood; Kora DeBeck
Journal:  AIDS Behav       Date:  2016-02

2.  A randomized controlled trial of guided self-change with minority adolescents.

Authors:  Eric F Wagner; Michelle M Hospital; Juliette N Graziano; Staci L Morris; Andrés G Gil
Journal:  J Consult Clin Psychol       Date:  2014-05-19

3.  Teaching and assessing residents' skills in managing heroin addiction with objective structured clinical examinations (OSCEs).

Authors:  Sharon J Parish; Melissa R Stein; Steven R Hahn; Uri Goldberg; Julia H Arnsten
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

4.  Reduction and Cessation of Alcohol, Cannabis, and Stimulant Use: Prospective Associations With Changes in Depressive Symptoms Across Two Cohort Studies of Sexual and Gender Minorities.

Authors:  Christina Dyar; Heather Bradley; Ethan Morgan; Patrick S Sullivan; Brian Mustanski
Journal:  J Stud Alcohol Drugs       Date:  2020-11       Impact factor: 2.582

5.  Injection Drug Users' Perceived Barriers to Using Self-Initiated Harm Reduction Strategies.

Authors:  Erin E Bonar; Harold Rosenberg
Journal:  Addict Res Theory       Date:  2014-08-01

6.  The availability and portrayal of stimulants over the Internet.

Authors:  Ty S Schepis; Douglas B Marlowe; Robert F Forman
Journal:  J Adolesc Health       Date:  2008-03-04       Impact factor: 5.012

7.  Acceptability of nonabstinent treatment outcome goals among addiction treatment providers in Ukraine.

Authors:  Alan K Davis; Tetiana Nickelsen; Robert A Zucker; Erin E Bonar; Maureen A Walton
Journal:  Psychol Addict Behav       Date:  2018-04-12

Review 8.  Communication Strategies to Counter Stigma and Improve Mental Illness and Substance Use Disorder Policy.

Authors:  Emma McGinty; Bernice Pescosolido; Alene Kennedy-Hendricks; Colleen L Barry
Journal:  Psychiatr Serv       Date:  2017-10-02       Impact factor: 3.084

9.  Chronic illness and multimorbidity among problem drug users: a comparative cross sectional pilot study in primary care.

Authors:  Walter Cullen; Sarah O'Brien; Austin O'Carroll; Fergus D O'Kelly; Gerard Bury
Journal:  BMC Fam Pract       Date:  2009-04-21       Impact factor: 2.497

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.